Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Biopharmaceutics of Nanomedicines: Opportunities and Challenges

*Corresponding Author:

Received Date: Jun 04, 2024 / Published Date: Jun 28, 2024

Copyright: © 0  . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Abstract :Nanomedicine, employing nanotechnology in medicine, offers innovative solutions for drug delivery and therapy. This article explores the biopharmaceutics of nanomedicines, focusing on their opportunities and challenges. Nanoscale drug delivery systems enhance bioavailability, enable targeted therapies, and facilitate combination treatments. However, concerns regarding safety, manufacturing scalability, and regulatory compliance remain. Future advancements rely on interdisciplinary collaboration and technological integration to optimize nanomedicine's efficacy and ensure its clinical translation.

Keywords

Top